Skip to main content

Table 3 The ASMR of VL in the years 1990 and 2021 and change trend of ASMR were analyzed across GBD regions

From: Global, regional, and national burden of visceral leishmaniasis, 1990–2021: findings from the global burden of disease study 2021

Location

ASMR (per 100,000 population, 95% UI)

1990

ASMR (per 100,000 population, 95% UI)

2021

Percentage change (95% UI)

1990–2021

AAPC (95% CI)

1990–2021

Global

1.05 (0.34, 3.36)

0.07 (0.02, 0.24)

−92.93 (−94.26, −90.65)

−0.03 (−0.04, −0.02)

East Asia

0.07 (0.00, 0.39)

0.01 (0.00, 0.06)

−84.43 (−87.36, −80.45)

−0.01 (−0.01, −0.00)

Southeast Asia

0.00 (0.00, 0.01)

0.00 (0.00, 0.01)

−83.40 (−85.96, −76.88)

−0.01 (−0.01, −0.00)

Central Asia

0.02 (0.00, 0.21)

0.04 (0.00, 0.32)

52.03 (38.30, 76.83)

0.01 (0.00, 0.01)

Central Europe

0.12 (0.00, 1.15)

0.01 (0.00, 0.05)

−95.29 (−96.08, −94.36)

−0.01 (−0.01, −0.00)

Western Europe

0.02 (0.01, 0.15)

0.01 (0.00, 0.04)

−71.68 (−74.91, −60.47)

−0.01 (−0.01, −0.00)

Southern Latin America

0.01 (0.00, 0.06)

0.00 (0.00, 0.01)

−74.55 (−76.71, −72.75)

−0.01 (−0.01, −0.00)

Caribbean

0.00 (0.00, 0.02)

0.00 (0.00, 0.01)

−90.81 (−92.91, −87.75)

−0.01 (−0.01, −0.00)

Andean Latin America

0.18 (0.00, 0.86)

0.01 (0.00, 0.05)

−94.35 (−95.82, −92.57)

−0.01 (−0.01, −0.00)

Central Latin America

0.02 (0.00, 0.16)

0.01 (0.00, 0.04)

−71.49 (−76.71, −62.45)

−0.01 (−0.01, −0.00)

Tropical Latin America

0.66 (0.00, 2.44)

0.51 (0.00, 1.80)

−23.28 (−30.61, −4.30)

−0.01 (−0.01, −0.00)

North Africa and the Middle East

0.86 (0.00, 6.88)

0.07 (0.00, 0.56)

−92.36 (−94.51, −90.96)

−0.03 (−0.03, −0.02)

South Asia

2.37 (0.00, 10.32)

0.07 (0.00, 0.35)

−97.06 (−98.03, −96.49)

−0.08 (−0.08, −0.07)

Central Sub-Saharan Africa

5.51 (2.92, 8.70)

0.37 (0.19, 0.61)

−93.24 (−94.43, −91.86)

−0.17 (−0.17, −0.16)

Eastern Sub-Saharan Africa

9.40 (6.40, 12.93)

0.31 (0.19, 0.47)

−96.66 (−97.51, −95.68)

−0.31 (−0.32, −0.30)

Western Sub-Saharan Africa

0.01 (0.01, 0.02)

0.04 (0.02, 0.06)

312.44 (230.37, 412.62)

0.01 (0.01, 0.02)

High SDI

0.01 (0.00, 0.06)

0.00 (0.00, 0.01)

−93.01 (−99.26, −91.20)

−0.01 (−0.01, −0.00)

High-middle SDI

0.05 (0.00, 0.45)

0.01 (0.00, 0.03)

−90.10 (−92.73, −50.61)

−0.01 (−0.01, −0.00)

Middle SDI

0.13 (0.00, 0.75)

0.02 (0.00, 0.11)

−81.02 (−84.68, −42.02)

−0.01 (−0.01, −0.00)

Low-middle SDI

0.96 (0.14, 3.89)

0.09 (0.01, 0.38)

−90.63 (−92.66, −88.63)

−0.03 (−0.03, −0.02)

Low SDI

7.66 (2.79, 21.15)

0.25 (0.10,0.59)

−96.80 (−97.64, −94.87)

−0.24 (−0.26, −0.24)

  1. The value “0.00” does not represent an absolute zero; rather, the actual value contains nonzero digits beyond the second decimal place, but owing to rounding (following the round half-up rule), it appears as “0.00” when displayed with two decimal places. In the GBD 2021 database, the world’s 204 countries and territories are categorized into 21 geographical regions. Among these, no data on the ASMR of VL were available for Oceania, Eastern Europe, high-income North America, high-income Asia Pacific, Australasia, and Southern Sub-Saharan Africa; AAPC average annual percent change, ASMR age-standardized mortality rate, CI confidence interval, GBD Global Burden of Disease, SDI sociodemographic index, UI uncertainty interval, VL visceral leishmaniasis